Anna Shrimpton

582 total citations
10 papers, 103 citations indexed

About

Anna Shrimpton is a scholar working on Immunology and Allergy, Immunology and Surgery. According to data from OpenAlex, Anna Shrimpton has authored 10 papers receiving a total of 103 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology and Allergy, 4 papers in Immunology and 3 papers in Surgery. Recurrent topics in Anna Shrimpton's work include Food Allergy and Anaphylaxis Research (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Infectious Diseases and Tuberculosis (2 papers). Anna Shrimpton is often cited by papers focused on Food Allergy and Anaphylaxis Research (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Infectious Diseases and Tuberculosis (2 papers). Anna Shrimpton collaborates with scholars based in United Kingdom, France and United States. Anna Shrimpton's co-authors include William Egner, Ravishankar Sargur, Duncan Chambers, Georgina Jones, Katharina Sophie Vogt, Mark Clowes, Martin Wiselka, G. Wild, Nelun Perera and Michael R. Barer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.

In The Last Decade

Anna Shrimpton

9 papers receiving 101 citations

Peers

Anna Shrimpton

IMMUN

PHARM

EPIDE

PHYSI

Narges Eslami Iran

Sepideh Darougar Iran

Rasol Molatefi Iran

Eirini Lagogianni Greece

Emília Faria Portugal

Marcela Valverde‐Monge Spain

Janis Cotter United States

Sergio Villazala‐Merino Austria

Alexandra Florescu Canada

A. Delcampe France

Narges Eslami Iran

Anna Shrimpton

54 ×1.3

IMMUN

36 ×0.9

6 ×0.2

PHARM

18 ×1.0

EPIDE

15 ×0.9

PHYSI

Citations per year, relative to Anna Shrimpton Anna Shrimpton (= 1×) peers Narges Eslami

Countries citing papers authored by Anna Shrimpton

Since Specialization

Citations

This map shows the geographic impact of Anna Shrimpton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Shrimpton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Shrimpton more than expected).

Fields of papers citing papers by Anna Shrimpton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Shrimpton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Shrimpton. The network helps show where Anna Shrimpton may publish in the future.

Co-authorship network of co-authors of Anna Shrimpton

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Shrimpton. A scholar is included among the top collaborators of Anna Shrimpton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Shrimpton. Anna Shrimpton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Jones, Georgina, et al.. (2020). <p>The Development of a New Questionnaire to Measure the Burden of Immunoglobulin Treatment in Patients with Primary Immunodeficiencies: The IgBoT-35</p>. Patient Preference and Adherence. Volume 14. 1567–1584. 2 indexed citations

Jones, Georgina, Eva Brown Hajdukova, Esmée Hanna, et al.. (2020). It’s long-term, well it’s for life basically: Understanding and exploring the burden of immunoglobulin treatment in patients with primary immunodeficiency disorders. SHILAP Revista de lepidopterología. 4(3). 9564–9564. 1 indexed citations

Rutkowski, Krzysztof, Leonard Siew, Alla Nakonechna, et al.. (2019). Flucloxacillin Hypersensitivity: Patient Outcomes in a Multicenter Retrospective Study. The Journal of Allergy and Clinical Immunology In Practice. 7(7). 2212–2217.e1. 11 indexed citations

Jones, Georgina, Katharina Sophie Vogt, Duncan Chambers, Mark Clowes, & Anna Shrimpton. (2018). What Is the Burden of Immunoglobulin Replacement Therapy in Adult Patients With Primary Immunodeficiencies? A Systematic Review. Frontiers in Immunology. 9. 1308–1308. 24 indexed citations

Egner, William, et al.. (2016). A 17‐year experience in perioperative anaphylaxis 1998–2015: harmonizing optimal detection of mast cell mediator release. Clinical & Experimental Allergy. 46(11). 1465–1473. 21 indexed citations

Basumani, Pandurangan, et al.. (2013). Utility of Testing Patients, on Presentation, for Serologic Features of Celiac Disease. Clinical Gastroenterology and Hepatology. 12(6). 946–952. 9 indexed citations

Murng, Sai, William Egner, Anna Shrimpton, & Ravishankar Sargur. (2013). Using Omega-5 Gliadin ( rTri a 19) in the Diagnosis of Anaphylaxis. Journal of Allergy and Clinical Immunology. 131(2). AB214–AB214.

Sargur, Ravishankar, Deborah Cowley, Sai Murng, et al.. (2011). Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay. Clinical & Experimental Immunology. 163(3). 339–345. 20 indexed citations

Malkin, Joanne, Anna Shrimpton, Martin Wiselka, et al.. (2009). Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behçet's disease. Journal of Medical Microbiology. 58(3). 371–373. 14 indexed citations

10.

Malkin, Joanne, Anna Shrimpton, Martin Wiselka, et al.. (2008). Olecranon Bursitis Secondary to Mycobacterium kansasii Infection in a Patient Receiving Infliximab for Behçet's Disease. International Journal of Infectious Diseases. 12. S43–S43. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact